198 related articles for article (PubMed ID: 15525445)
21. Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling.
Meibohm B; Derendorf H
Int J Clin Pharmacol Ther; 1997 Oct; 35(10):401-13. PubMed ID: 9352388
[TBL] [Abstract][Full Text] [Related]
22. Comparative population pharmacokinetic-pharmacodynamic analysis for piroxicam-beta-cyclodextrin and piroxicam.
Wang D; Miller R; Zheng J; Hu C
J Clin Pharmacol; 2000 Nov; 40(11):1257-66. PubMed ID: 11075311
[TBL] [Abstract][Full Text] [Related]
23. The effects of long-term administration of oral desmopressin on the baseline secretion of antidiuretic hormone and serum sodium concentration for the treatment of nocturia: a circadian study.
Bae JH; Oh MM; Shim KS; Cheon J; Lee JG; Kim JJ; Moon DG
J Urol; 2007 Jul; 178(1):200-3. PubMed ID: 17499799
[TBL] [Abstract][Full Text] [Related]
24. Effect of intranasal histamine on nasal mucosal blood flow and the antidiuretic activity of desmopressin.
Olanoff LS; Titus CR; Shea MS; Gibson RE; Brooks CD
J Clin Invest; 1987 Sep; 80(3):890-5. PubMed ID: 3624491
[TBL] [Abstract][Full Text] [Related]
25. A new fast-melting oral formulation of desmopressin: a pharmacodynamic study in children with primary nocturnal enuresis.
Vande Walle JG; Bogaert GA; Mattsson S; Schurmans T; Hoebeke P; Deboe V; Norgaard JP;
BJU Int; 2006 Mar; 97(3):603-9. PubMed ID: 16469035
[TBL] [Abstract][Full Text] [Related]
26. Desmopressin in the treatment of nocturia: a double-blind, placebo-controlled study.
van Kerrebroeck P; Rezapour M; Cortesse A; Thüroff J; Riis A; Nørgaard JP
Eur Urol; 2007 Jul; 52(1):221-9. PubMed ID: 17280773
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
[TBL] [Abstract][Full Text] [Related]
28. [Clinical evaluation of desmopressin (DDAVP) in diabetes insipidus: solution vs tablets].
Rampazzo AL; Boscaro M; Mantero F; Piccitto R
Minerva Endocrinol; 1992; 17(1):37-41. PubMed ID: 1495453
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics and antidiuretic effect of intravenous administration of desmopressin in orally overhydrated male volunteers.
Callréus T; Höglund P
Pharmacol Toxicol; 1998 Dec; 83(6):259-62. PubMed ID: 9868744
[TBL] [Abstract][Full Text] [Related]
30. Clinical observations of the effect of antidiuretic hormone on nocturia in elderly men.
Ho DR; Lin WY; Wu CF; Shee JJ; Huang YC; Chen CS
BJU Int; 2005 Dec; 96(9):1310-3. PubMed ID: 16287451
[TBL] [Abstract][Full Text] [Related]
31. Claiming desmopressin therapeutic equivalence in children requires pediatric data: a population PKPD analysis.
Michelet R; Dossche L; Van Herzeele C; Van Bocxlaer J; Vermeulen A; Vande Walle J;
Eur J Clin Pharmacol; 2018 Mar; 74(3):297-305. PubMed ID: 29198064
[TBL] [Abstract][Full Text] [Related]
32. Desmopressin resistant nocturnal polyuria may benefit from furosemide therapy administered in the morning.
De Guchtenaere A; Vande Walle C; Van Sintjan P; Donckerwolcke R; Raes A; Dehoorne J; Van Laecke E; Hoebeke P; Vande Walle J
J Urol; 2007 Dec; 178(6):2635-9; discussion 2639. PubMed ID: 17945291
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics and antidiuretic effect of high-dose desmopressin in patients with chronic renal failure.
Ruzicka H; Björkman S; Lethagen S; Sterner G
Pharmacol Toxicol; 2003 Mar; 92(3):137-42. PubMed ID: 12753429
[TBL] [Abstract][Full Text] [Related]
34. Desmopressin tablet treatment: factors influencing gastrointestinal absorption.
Rittig S; Jensen AR; Jensen KT; Pedersen EB
Scand J Urol Nephrol Suppl; 1997; 183():51-2. PubMed ID: 9165607
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of desmopressin administrated as an oral lyophilisate dosage form in children with primary nocturnal enuresis and healthy adults.
Osterberg O; Savic RM; Karlsson MO; Simonsson US; Nørgaard JP; Walle JV; Agersø H
J Clin Pharmacol; 2006 Oct; 46(10):1204-11. PubMed ID: 16988210
[TBL] [Abstract][Full Text] [Related]
36. Investigation of PK-PD drug-drug interaction between acenocoumarol and amoxicillin plus clavulanic acid.
Delavenne X; Laporte S; Demasles S; Mallouk N; Basset T; Tod M; Girard P; Mismetti P
Fundam Clin Pharmacol; 2009 Feb; 23(1):127-35. PubMed ID: 19267776
[TBL] [Abstract][Full Text] [Related]
37. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.
Giannini S; Mezzasoma AM; Leone M; Gresele P
Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988
[TBL] [Abstract][Full Text] [Related]
38. Short-term effects of desmopressin on water and electrolyte excretion in adults with nocturnal polyuria.
Chang YL; Lin AT; Chen KK
J Urol; 2007 Jun; 177(6):2227-9; discussion 2230. PubMed ID: 17509326
[TBL] [Abstract][Full Text] [Related]
39. Comparative study of the multiple dose pharmacokinetics and the tolerance of a new NSAID (droxicam) versus piroxicam in healthy volunteers.
Martínez L; Sánchez J; Roser R; García-Barbal J; Bartlett A; Estruch J; Sagarra R; Puig S; Costa A
Methods Find Exp Clin Pharmacol; 1988 Nov; 10(11):729-37. PubMed ID: 3221746
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of the urinary concentration defect and effect of desmopressin during endotoxemia in rats.
Versteilen AM; Heemskerk AE; Groeneveld AB; van Wijhe M; van Lambalgen AA; Tangelder GJ
Shock; 2008 Feb; 29(2):217-22. PubMed ID: 17693923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
